CHARLESTON, W.Va.--(BUSINESS WIRE)--Paragon Intellectual Properties, LLC (Paragon IP), the holding company for six medical device development subsidiaries, each possessing highly specialized and innovative intellectual property, is pleased to announce today the attainment of initial commitments of $15 million in funding. The investments come primarily from private investors in West Virginia in addition to equity stakes from two major medical device manufacturers. This funding will enable Paragon IP to obtain the engineering talent and infrastructure required to fulfill its near-term goal of optimizing and commercializing two of its pioneering therapies in the rapidly expanding field of minimally invasive treatments for cardiovascular disease.
